Arrowhead Pharmaceuticals, Inc. (ARWR) Profit Margins
Over the twelve months to 2026-06-30, Arrowhead Pharmaceuticals, Inc. (ARWR) had operating margin -33.8%, net margin -47.8%, free cash flow margin -11.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ARWRArrowhead Pharmaceuticals, Inc.Follow ARWR — free
—
Price chart with a free account
- Market cap
- 8.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 23 Nov, in 30 days
| Line | FY2011 Sep 11 | FY2012 Sep 12 | FY2013 Sep 13 | FY2014 Sep 14 | FY2015 Sep 15 | FY2016 Sep 16 | FY2017 Sep 17 | FY2018 Sep 18 | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | 52.0% | — | — | — | — | — | — | — | |
| Operating margin | -3319.5% | -14358.6% | -8471.3% | -30443.6% | -25124.1% | -51627.1% | -117.8% | -346.5% | 36.3% | -105.9% | -107.8% | -73.4% | -85.2% | -16927.1% | 11.9% | -33.8% | |
| Net margin | -1056.6% | -14383.6% | -10729.2% | -33503.0% | -24068.3% | -51614.6% | -109.5% | -337.3% | 40.3% | -96.1% | -101.9% | -72.4% | -85.3% | -16882.4% | -0.2% | -47.8% | |
| FCF margin | -2588.5% | -10770.9% | -6659.3% | -21219.3% | -17716.8% | -43129.2% | -101.4% | -301.3% | 95.4% | -122.5% | 106.8% | -77.7% | -137.3% | -17018.3% | 18.9% | -11.2% |
USD billions · SEC XBRL
Arrowhead Pharmaceuticals, Inc. — questions
- What is Arrowhead Pharmaceuticals, Inc.'s operating margin?
- -33.8% over the twelve months to 2026-06-30.
- What is Arrowhead Pharmaceuticals, Inc.'s net profit margin?
- -47.8% over the twelve months to 2026-06-30.
Every figure on this page comes from Arrowhead Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.